Medindia

X

Valeant Pharmaceuticals Reports 2009 Fourth Quarter and Full Year Financial Results

Monday, February 22, 2010 Corporate News J E 4
Advertisement
- Fourth quarter revenue $240.5 million; Full year 2009 revenue $830.5 million

Contact:

Laurie W. Little

Valeant Pharmaceuticals

949-461-6002

laurie.little@valeant.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Watson Files FDA Application for Generic Aplenzin(...
S
Ascension Orthopedics Introduces the MOVEMENT(TM) ...